EQ Shareowner Services (formerly Wells Fargo Shareowner Services) is our transfer and record-keeping agent and administers all matters related to our stock.
To learn more about or to purchase our stock online through EQ Shareowner Services, please visit https://www.shareowneronline.com
To request an enrollment package by phone:
- 1-855-598-5485 toll-free within the U.S.
- 1-651-450-4064 from outside the U.S.
A telecommunications relay service should be used by the hearing impaired when calling the telephone numbers above.
To contact in writing:
EQ Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120
Check Your Account
You may complete the following transactions online at http://www.shareowneronline.com:
- Change address
- Purchase more shares for as little as $50 or as much as $10,000
- Get dividend information
- Obtain your account balance
- Sell shares
- Automatically invest your cash dividends
- View tax information
- Order a paper stock certificate
If your stock is held by a broker, please contact your broker.
FAQs for BMY Shareholders
Where are Bristol Myers Squibb shares traded?
What is Bristol Myers Squibb's ticker symbol?
Who is the transfer agent for Bristol Myers Squibb?
When does Bristol Myers Squibb pay dividends?
How do I sign up for the direct deposit of dividends service?
Does Bristol Myers Squibb offer dividend reinvestment?
Does Bristol Myers Squibb offer direct stock purchase?
What is a record date?
What does it mean when stock is purchased "ex-dividend"?
What is a "street name" or beneficial holder?
What does book-entry form mean?
What is a capital gain/loss?
When is the annual meeting of shareholders?
Cost Basis Calculator
For a fee, you may use NetBasis to calculate the cost basis for your Bristol Myers Squibb Company common stock, adjusted for any corporate actions or dividend reinvestments.
Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol Myers Squibb website or from Bristol Myers Squibb Investor Relations.
In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.